NCT07576283 Comparative Effects of Hypopressive and Transverses Abdominis Focused Core Training in Postpartum
| NCT ID | NCT07576283 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Postpartum |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-10-01 |
| Primary Completion | 2026-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-10-01 with a primary completion date of 2026-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aims to compare the effectiveness of these two core training approaches in improving urinary incontinence, pelvic floor function, and quality of life in postpartum women.
Eligibility Criteria
Inclusion Criteria: * Multiparous women with urinary incontinence * Who had undergone normal vaginal delivery * Free from any medical and gynecological risk factors and /or conditions * Stress urinary incontinence test is positive: Pad test Exclusion Criteria: * Had neurological impairments or connective tissue disorders * Active urinary or vaginal infection in the past 3 months * Had known detrusor instability * Had undergone previous surgery to alleviate SUI * Had pelvic organ prolapse
Contact & Investigator
hina gul, PhD*
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07576283 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 35 Years, studying Postpartum. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07576283 currently recruiting?
Yes, NCT07576283 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07576283 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07576283 clinical trial?
NCT07576283 is sponsored by Riphah International University. The principal investigator is hina gul, PhD* at Riphah International University. The trial plans to enroll 60 participants.